Viking Therapeutics (VKTX) Share-based Compensation (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Share-based Compensation came in at $11.1 million in Q2 2026, down 17.82% year-over-year from $13.5 million in Q2 2025, and up 7.7% quarter-over-quarter from $10.3 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Share-based Compensation (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Share-based Compensation across 13 years of filings, most recently posting $11.1 million for Q2 2026.
- In Q2 2026, Share-based Compensation fell 17.82% year-over-year to $11.1 million; the TTM figure through Jun 2026 stood at $37.4 million (up 10.38% YoY), while the FY2025 annual figure was $40.8 million, down 3.05% from the prior year.
- Share-based Compensation came in at $11.1 million for Q2 2026 at Viking Therapeutics, up from $10.3 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $42.1 million in Q1 2024 to a low of $2.2 million in Q4 2022.
- Average Share-based Compensation over 5 years is $9.3 million, with a median of $7.1 million recorded in 2024.
- Year-over-year, Share-based Compensation jumped 630.67% in 2024 and plunged 73.05% in 2025.
- Over 5 years, Share-based Compensation stood at $2.2 million in 2022, then jumped by 89.24% to $4.1 million in 2023, then soared by 120.15% to $9.0 million in 2024, then decreased by 4.4% to $8.6 million in 2025, then advanced by 29.65% to $11.1 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $11.1 million in Q2 2026, $10.3 million in Q1 2026, and $8.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -950.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 247.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 108.10 Mn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 11.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.13 Mn |
| Mar 31, 2026 | 10.34 Mn |
| Dec 31, 2025 | 8.59 Mn |
| Sep 30, 2025 | 7.34 Mn |
| Jun 30, 2025 | 13.55 Mn |
| Mar 31, 2025 | 11.35 Mn |
| Sep 30, 2024 | 8.98 Mn |
| Jun 30, 2024 | 7.08 Mn |
| Mar 31, 2024 | 42.10 Mn |
| Dec 31, 2023 | 4.08 Mn |
| Sep 30, 2023 | 5.24 Mn |
| Jun 30, 2023 | 5.16 Mn |
| Mar 31, 2023 | 5.76 Mn |
| Dec 31, 2022 | 2.16 Mn |
| Sep 30, 2022 | 5.11 Mn |
| Jun 30, 2022 | 5.10 Mn |
| Mar 31, 2022 | 5.07 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 3.93 Mn |
| Jun 30, 2021 | 3.92 Mn |
API Access
Viking Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();